Exact Sciences to Present New Molecular Residual Disease and Multi-Cancer Early Detection Data at AACR 2026 [Yahoo! Finance]
Exact Sciences Corporation (EXAS)
Last exact sciences corporation earnings: 2/11 04:05 pm
Check Earnings Report
US:NASDAQ Investor Relations:
investor.exactsciences.com/investor-relations/default.aspx
Company Research
Source: Yahoo! Finance
MADISON, Wis., March 17, 2026 BUSINESS WIRE )--Exact Sciences Corp. (NASDAQ: EXAS), a leading provider of cancer screening and diagnostic tests, today announced four presentations at the 2026 American Association for Cancer Research (AACR) Annual Meeting highlighting new data in molecular residual disease (MRD) testing and multi-cancer early detection (MCED). The meeting will take place from April 17–22, 2026, in San Diego, CA. Exact Sciences will present new findings from the NSABP B-59/GBG-96-GeparDouze trial evaluating its tumor-informed circulating tumor DNA (ctDNA) test, Oncodetect ® , in early triple-negative breast cancer (TNBC), along with updated performance data from its multi-biomarker class MCED program supporting the Cancerguard ® test. Together, these results reinforce the company's strategy to help detect cancer earlier and monitor disease after treatment. "Our goal is to use molecular information to guide cancer care at every stage," said Jorge Garces, Ph.D., chie
Show less
Read more
Impact Snapshot
Event Time:
EXAS
Last Price
Price Change
Price Change%
Volume Shares
Max Up
Max Down
%
Volume Ratio
Performance Comparison
Updated
|
Event Day
Stock performance from the time of news release until the following 4pm ET market close
|
Last price at news event
|
Since Event
Multi-day stock performance from the time of the news release
|
|---|---|---|
|
EVENT DAY
Stock performance from the time of news release until the following 4pm ET market close
|
LAST
PRICE AT NEWS EVENT |
SINCE EVENT
Multi-day stock performance from the time of the news release
|
| Last Price | ||
| VWAP | ||
|
High:
|
Max Up |
High:
|
|
Low:
|
Max Down |
Low:
|
|
%
|
Post news range |
%
|
|
|
Price change |
|
|
|
Price Change Percentage |
|
|
|
S&P 500 (SPX) |
|
|
%
|
Volume ratio |
%
|
| Volume | ||
| Ticks | ||
|
|
Avg transaction size |
|
Don't Miss Out On The Next BIG Stock Move
Event day
Event Day Chart will not be displayed beyond 90-day period of the event
Performance since event
Time And Velocity Analysis
Be the first to know
Opt in for alerts from News Quantifed
Sign Up Today
Opt-in for
EXAS alerts
Learn More With NQ
Reading the Impact Report
Help Me Understand This Data
Help Me Understand This Data
How NQ Works
What is news-based trading?
And why is it so successful?
And why is it so successful?
Movers & Shakers
The biggest gainers and losers and WHY it moved
EXAS alerts
High impacting Exact Sciences Corporation news events
Weekly update
A roundup of the hottest topics
EXAS
News
- Abbott acquisition of Exact Sciences set to close on March 23, 2026 [Yahoo! Finance]Yahoo! Finance
- Fidelity Mid-Cap Stock Fund Q4 2025 Commentary [Seeking Alpha]Seeking Alpha
- Fidelity Large Cap Stock Fund Q4 2025 Commentary [Seeking Alpha]Seeking Alpha
- Exact Sciences to Present New Molecular Residual Disease and Multi-Cancer Early Detection Data at AACR 2026Business Wire
- What to know about Cologuard Classic in Tucson on PGA Tour Champions [USA TODAY]USA TODAY
EXAS
Earnings
- 2/13/26 - Miss
EXAS
Sec Filings
- 3/20/26 - Form 8-K
- 3/3/26 - Form 4
- 3/3/26 - Form 4
- EXAS's page on the SEC website